Literature DB >> 28468521

Understanding cancer lineage plasticity: reversing therapeutic resistance in metastatic prostate cancer.

Leigh Ellis1,2.   

Abstract

Entities:  

Keywords:  Androgen receptor; EZH2; castrate-resistant prostate cancer; epigenetic therapy; lethal prostate cancer; lineage plasticity; neuroendocrine; prostate cancer metastasis

Mesh：

Year:  2017        PMID： 28468521     DOI： 10.2217/pgs-2017-0039

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  3 in total

1.  The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target.

Authors:  Michelle Shen; Shiqin Liu; Tanya Stoyanova
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

2.  BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models.

Authors:  Arsheed A Ganaie; Firdous H Beigh; Matteo Astone; Marina G Ferrari; Raihana Maqbool; Syed Umbreen; Aijaz S Parray; Hifzur R Siddique; Tabish Hussain; Paari Murugan; Colm Morrissey; Shahriar Koochekpour; Yibin Deng; Badrinath R Konety; Luke H Hoeppner; Mohammad Saleem
Journal:  Clin Cancer Res       Date:  2018-08-07       Impact factor: 12.531

Review 3.  Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.

Authors:  Zachary S Dovey; Sujit S Nair; Dimple Chakravarty; Ashutosh K Tewari
Journal:  Cancer Rep (Hoboken)       Date:  2021-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.